CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for KoBioLabs Inc (Parent) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

KoBioLabs Inc (Parent)
628, 220 Dong, Research Institute of Bio
Phone: +82 28889964p:+82 28889964 SEOUL, 08826  South Korea Fax: +82 28889940f:+82 28889940

Business Summary
KoBioLabs Inc is a Korea-based company mainly engaged in the development and sales of functional probiotics. The Company's products are sold under the names of Bioviom and Queens henna FOODOLOGY. The Company is also engaged in the development of new microbiome drugs. In addition, the Company engages in commissioned research. The Company sells its products in domestic and overseas markets.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202012/31/2019Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director Gwang PyoGoh 52 8/1/2022

General Information
Outstanding Shares: 18,872,208 (As of 6/28/2023)
Fax Number: +82 28889940


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, September 6, 2023